NCIt definition : A humanized monoclonal antibody directed against the human alpha v integrin subunit
with potential antiangiogenic and antineoplastic activities. Abituzumab, a chimeric
antibody which includes the antigen binding sites of the anti-integrin mouse antibody
17E6, binds to and inhibits the activity of alphaVbeta3 integrin (vitronectin receptor);
this may result in the inhibition of endothelial cell-cell interactions, endothelial
cell-matrix interactions, and integrin-mediated tumor angiogenesis and metastasis
in alphavbeta3-expressing tumor cells. AlphaVbeta3 integrin, a cell adhesion and signaling
receptor, is expressed on the surface of tumor vessel endothelial cells and plays
a crucial role in endothelial cell adhesion and migration.;
UNII : 724QD330RD;
CAS number : 1105038-73-0; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 1105038-73-0
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;